Ostronic Francis Patrick 4
4 · Cyclo Therapeutics, Inc. · Filed May 4, 2022
Insider Transaction Report
Form 4
Ostronic Francis Patrick
Director
Transactions
- Award
Common Stock
2022-05-03+5,249→ 133,525 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of 2.62 per share of common stock on May 2, 2022.